Treg cytokine IL-10, which has been coupled with the activation of JAK-STAT1 or STAT3 signaling cascade [26, 27] and found high expression in liver fibrotic tissues, was used to reverse therapeutic effect of IL-17A antibody in TAA-induced hepatic fibrosis mice. This evidence concerns the gene STAT1 and Hepatic fibrosis.